The Use of Pharmacoscintigraphy to Elucidate Food Effects Observed with a Novel Protease Inhibitor (Saquinavir)
暂无分享,去创建一个
[1] H. Burger,et al. Safety and activity of saquinavir in HIV infection , 1995, The Lancet.
[2] A. Roda,et al. Bile acid structure and intestinal absorption in the animal model. , 1995, The Italian journal of gastroenterology.
[3] I. Wilding,et al. Gastrointestinal transit of a drug-resinate administered as an oral suspension , 1994 .
[4] W. Ritschel,et al. Gastrointestinal parameters that influence oral medications. , 1993, Journal of pharmaceutical sciences.
[5] I. Wilding,et al. The Effect of Meal Composition on the Gastrocolonic Response: Implications for Drug Delivery to the Colon , 1993, Pharmaceutical Research.
[6] Erik De Clercq,et al. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives , 1990, Nature.
[7] S. Davis,et al. Transit of pharmaceutical dosage forms through the small intestine. , 1986, Gut.
[8] E. Reddy,et al. HTLV-III gag protein is processed in yeast cells by the virus pol-protease. , 1986, Science.
[9] J. Mcewen,et al. The effect of in‐vivo dispersion and gastric emptying on glibenclamide absorption from a novel, rapidly dissolving capsule formulation , 1984, The Journal of pharmacy and pharmacology.
[10] C F Code,et al. The interdigestive myo‐electric complex of the stomach and small bowel of dogs. , 1975, The Journal of physiology.
[11] J. N. Hunt,et al. The volume and energy content of meals as determinants of gastric emptying. , 1975, The Journal of physiology.
[12] N. LaRusso,et al. Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption. , 1974, The New England journal of medicine.
[13] J. N. Hunt,et al. The influence of volume on gastric emptying , 1954, The Journal of physiology.
[14] I. Wilding,et al. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms , 2004, European Journal of Nuclear Medicine.